Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
用户EO9nReo4Hj6s
1个月前
106
10
已完结
1. 系统已在2026-07-24 10:35:08对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jtho.2026.103980
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086426004338
其他信息:
出版社: Elsevier BV
作者: Ana Baramidze; Tamta Makharadze; Miranda Gogishvili; Tamar Melkadze; Davit Giorgadze; Konstantin Penkov; Konstantin Laktionov; Gia Nemsadze; Marina Nechaeva; Irina Rozhkova; Ewa Kalinka; Yuntong Li; Debra A.G. McIntyre; Xue Jia; Javier Perez; Manika Kaul; Israel Lowy; Jean-Francois Pouliot; Stefanie Chua; Eric Kim; Frank Seebach; Heather Magnan
